SCHEDULE: iBio Stakeholder Update: Sirenia Capital Management Discloses Ownership

Sirenia Capital Management LP and Alex Silverstein report beneficial ownership of 9.9% of iBio, Inc. common stock, primarily through warrants, subject to a 9.99% ownership blocker.

Summary

• Sirenia Capital Management LP and Alex Silverstein have jointly filed a Schedule 13G, indicating their beneficial ownership of 9.9% of iBio, Inc.'s common stock.
• This ownership stake includes 11,586,340 shares of common stock, with a significant portion (10,710,000 shares) issuable upon the exercise of warrants.
• The exercise of these warrants is subject to a '9.99% Blocker' provision, which limits the number of shares that can be exercised to maintain beneficial ownership below this threshold.
• As a result, the Reporting Persons cannot currently exercise all of their warrants due to this blocker.
• The filing is made as of March 31, 2026, with the outstanding shares of common stock calculated as of February 24, 2026, based on iBio's prospectus.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing. It discloses significant ownership and potential future stake via warrants, but the presence of an ownership blocker limits immediate upside and indicates a controlled approach to investment.

Positives

• Sirenia Capital Management LP and Alex Silverstein have a significant beneficial ownership stake of 9.9% in iBio, Inc., indicating substantial investor interest.
• The ownership is primarily derived from warrants, suggesting a potential for increased equity ownership upon exercise, subject to limitations.

Negatives

• The exercise of a substantial portion of the warrants (10,710,000 shares) is currently restricted by a 9.99% ownership blocker, preventing full exercise of these rights.
• The actual number of shares beneficially owned, after giving effect to the blocker, is less than what would be issuable upon full warrant exercise.

Risks

• The 9.99% ownership blocker limits the Reporting Persons' ability to fully exercise their warrants, potentially impacting their intended ownership level and influence.
• Future exercise of warrants is contingent on maintaining beneficial ownership below the 9.99% threshold, which could be affected by other share issuances or market conditions.

Future Outlook

The future outlook for the Reporting Persons' ownership is tied to their ability to navigate the 9.99% ownership blocker. They are unable to exercise all of their warrants at this time due to this restriction, implying a cautious approach to increasing their stake until conditions allow or the blocker is no longer a constraint.

Management Comments

• The filing should not be construed as an admission that any of the Reporting Persons is, for the purposes of Section 13 of the Securities Exchange Act of 1934, the beneficial owner of the securities reported herein.
• Sirenia and Mr. Silverstein have entered into a Joint Filing Agreement, agreeing to file this Schedule 13G jointly.
• The Reporting Persons acknowledge that each shall be responsible for the timely filing of amendments and for the completeness and accuracy of the information concerning him or it, but shall not be responsible for the completeness and accuracy of the information concerning the others, except to the extent they know or have reason to believe it is inaccurate.

Industry Context

StockSavvy.ai notes that this Schedule 13G filing by Sirenia Capital Management LP and Alex Silverstein highlights active institutional interest in iBio, Inc. The disclosure of significant warrant holdings, coupled with an ownership blocker, is a common strategy for investors to acquire substantial stakes while managing regulatory thresholds and potential market impact.

Stakeholder Impact

• Shareholders: The disclosure of a significant stake by Sirenia Capital Management LP and Alex Silverstein may signal increased investor interest or potential future activity in the stock. The ownership blocker, however, tempers immediate expectations of a large share acquisition.
• Management: The filing provides transparency on a major beneficial owner, which is a standard part of corporate governance and investor relations.
• Creditors: No direct impact on creditors is indicated by this filing.

Next Steps

• The Reporting Persons will continue to monitor their beneficial ownership levels in relation to the 9.99% Blocker.
• Future amendments to this Schedule 13G will be filed as required by SEC regulations.

Key Dates

Keywords

iBio, Schedule 13G, Sirenia Capital Management LP, Alex Silverstein, Beneficial Ownership, Warrants, Ownership Blocker, SEC Filing, Investment Management